Tech Company Financing Transactions
Encycle Therapeutics Funding Round
On 11/12/2014, Encycle Therapeutics secured $2.5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
11/12/2014
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The capital infusion is intended to support the company's drug development platform, which is focused on treating inflammatory bowel disease and related conditions.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 College St. 314
Toronto ON, M5G 1L7
Canada
Toronto ON, M5G 1L7
Canada
Phone
Website
Email Address
Not Recorded
Overview
Encycle Therapeutics is a biopharmaceutical company exploiting a proprietary platform technology that enables the rapid synthesis of small-to-medium macrocycles.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Raphael Hofstein
Chief Executive Officer
Jeffrey Coull
Founder
Andrei Yudin
VP - Operations
Andrew Roughton
Browse more venture capital transactions:
Prev: 11/12/2014: CareLuLu venture capital transaction
Next: 11/12/2014: ApplePie Capital venture capital transaction
Share this article
About Database of VC Transactions
We record all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs